Zumla, Alimuddin

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet

Global Health and EpidemiologyInsurance, Mortality, Demography, Risk Management

Cited by 5,112

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 4,681

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 3,809

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 3,791

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology

Cited by 2,889

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet

Cardiovascular Health and Risk FactorsGlobal Public Health Policies and Epidemiology

Cited by 2,884

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Ikuta, K. S., Swetschinski, L. R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A. P., Davis Weaver, N., Wool, E. E., Han, C., Gershberg Hayoon, A., et al. (2022) · The Lancet

Antibiotic Use and ResistanceGlobal Health and Epidemiology

Cited by 2,235

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,435

Hospital outbreak of Middle East respiratory syndrome coronavirus

Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., Alabdullatif, Z. N., Assad, M., Almulhim, A., Makhdoom, H., et al. (2013) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks Research

Cited by 1,196

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abd ElHafeez, S., Abdelmasseh, M., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementCOVID-19 epidemiological studies

Cited by 1,045

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Hay, S. I., Ong, K. L., Santomauro, D. F., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abate, B. B., Abbafati, C., et al. (2025) · The Lancet

Global Health and EpidemiologyCardiovascular Health and Risk Factors

Cited by 916

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Naghavi, M., Kyu, H. H., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abafita, B. J., Abaraogu, U. O., Abbafati, C., Abbasi, M., et al. (2025) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology

Cited by 595

Reducing mortality from 2019-nCoV: host-directed therapies should be an option.

Zumla, A., Hui, D. S., Azhar, E. I., Memish, Z. A., & Maeurer, M. (2020) · The Lancet

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 429

Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon

Huggett, J. F., Novak, T., Garson, J. A., Green, C., Morris-Jones, S. D., Miller, R. F., & Zumla, A. (2008) · BMC Research Notes

Molecular Biology Techniques and ApplicationsClinical Laboratory Practices and Quality Control

Cited by 250

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1

Galles, N. C., Liu, P. Y., Updike, R. L., Fullman, N., Nguyen, J., Rolfe, S., Sbarra, A. N., Schipp, M. F., Marks, A., Abady, G. G., et al. (2021) · The Lancet

Vaccine Coverage and HesitancyGlobal Maternal and Child Health

Cited by 215

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

Schumacher, A. E., Zheng, P., Barber, R. M., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abbafati, C., Abbas, N., et al. (2025) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Cancer Incidence and Screening

Cited by 209

Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

McNerney, R., Maeurer, M., Abubakar, I., Marais, B., Mchugh, T. D., Ford, N., Weyer, K., Lawn, S., Grobusch, M. P., Memish, Z., et al. (2012) · The Journal of Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 191

Clinical Aspects of Adult Tuberculosis

Loddenkemper, R., Lipman, M., & Zumla, A. (2016) · Cold Spring Harbor Perspectives in Medicine

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 140

Antimicrobial resistance preparedness in sub-Saharan African countries

Elton, L., Thomason, M. J., Tembo, J., Velavan, T. P., Pallerla, S. R., Arruda, L. B., Vairo, F., Montaldo, C., Ntoumi, F., Abdel Hamid, M. M., et al. (2020) · Antimicrobial Resistance & Infection Control

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 125

Contact tracing and the COVID-19 response in Africa: best practices, key challenges, and lessons learned from Nigeria, Rwanda, South Africa, and Uganda

Nachega, J. B., Atteh, R., Ihekweazu, C., Sam-Agudu, N. A., Adejumo, P., Nsanzimana, S., Rwagasore, E., Condo, J., Paleker, M., Mahomed, H., et al. (2021) · The American Journal of Tropical Medicine and Hygiene

COVID-19 Digital Contact TracingCOVID-19 epidemiological studies

Cited by 104

Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa

Nachega, J. B., Kapata, N., Sam-Agudu, N. A., Decloedt, E. H., Katoto, P. D. M. C., Nagu, T., Mwaba, P., Yeboah-Manu, D., Chanda-Kapata, P., Ntoumi, F., et al. (2021) · International Journal of Infectious Diseases

Tuberculosis Research and EpidemiologyHIV/AIDS Research and Interventions

Cited by 80

The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread

Nachega, J., Seydi, M., & Zumla, A. (2020) · Clinical Infectious Diseases

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 76

Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security

Zumla, A., & Niederman, M. S. (2020) · Current Opinion in Pulmonary Medicine

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 49

A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana

Danso, E. K., Asare, P., Otchere, I. D., Akyeh, L. M., Asante-Poku, A., Aboagye, S. Y., Osei-Wusu, S., Opare, D., Ntoumi, F., Zumla, A., et al. (2020) · PLOS ONE

Vibrio bacteria research studiesSalmonella and Campylobacter epidemiology

Cited by 28